Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2023 Earnings Call Transcript August 8, 2023
Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.34 EPS, expectations were $0.47.
Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. I...
